Absci Corporation Appoints Gerry Muhle as Chief Commercial Officer
Position
Chief Commercial Officer
Company
AbSci Corp
VancouverManufacturingBiotechnologyHealth CareArtificial IntelligenceTherapeuticsBiopharmaDescription
Absci Corporation has appointed Gerry Muhle as Chief Commercial Officer to lead its commercial strategy. With over 25 years of experience in commercializing prescription medicines and consumer brands, Mr. Muhle aims to advance the company’s pipeline and strategic objectives.
Quick answer
Absci Corporation Appoints Gerry Muhle as Chief Commercial Officer (November 12, 2026). AbSci Corp is based in Vancouver, Washington, United States.
- Who is the new Chief Commercial Officer at AbSci Corp?
- AbSci Corp named Gerry Muhle Chief Commercial Officer, announced November 12, 2026.
- What did AbSci Corp announce on November 12, 2026?
- Absci Corporation has appointed Gerry Muhle as Chief Commercial Officer to lead its commercial strategy. With over 25 years of experience in commercializing prescription medicines and consumer brands, Mr. Muhle aims to advance the company’s pipeline and strategic objectives.
- Where did Gerry Muhle work before joining AbSci Corp?
- Gerry Muhle joins from Galderma.
- What does AbSci Corp do?
- Absci is a generative AI drug creation company.
- Where is AbSci Corp based?
- AbSci Corp is based in Vancouver, Washington, United States.
- Which similar companies made leadership changes around the same time?
- AbbVie Inc. (November 2, 2026), Gyre Therapeutics (October 22, 2026), Jazz Pharmaceuticals plc (October 9, 2026) and Cerenome, Inc. (November 12, 2026) also announced leadership changes within 45 days of AbSci Corp.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- Gyre Therapeutics Appoints Ying Luo as CEO and Thomas Eastling as CFO (October 22, 2026)
- Jazz Pharmaceuticals Announces Transition in Leadership (October 9, 2026)
- Cerenome, Inc. Appoints Ronald A. Andrews as Chief Business Officer (November 12, 2026)
- Nurix Therapeutics Appoints Arati V. Rao, M.D., as Chief Medical Officer (November 12, 2026)
- Candel Therapeutics names Maria Ostrovsky General Counsel (November 6, 2026)
Who to call at AbSci Corp, and when
A new leader at AbSci Corp brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day AbSci Corp raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AbSci Corp, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AbSci Corp. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AbSci Corp changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
AbSci Corp changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.